Clinical trial
Evaluating Frontal Pole as a Window to Modulation of Cognitive Control in OCD
NCT07419009 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Frontal Pole as a Window to Modulation of Cognitive Control in OCD
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- September 30, 2027
- Enrollment
- 12 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
obsessive-compulsive disorder (ocd)